Skip to content
123 Main Street, New York, NY 10001
123-456-7890
About EMAS
Mission & vision
Contact
Membership
Scientific Resources
Guidelines & Resources
Maturitas journal
Case Reports in Women’s Health
Research Update
Education
Upcoming EMAS Webinars
Webinars on-demand
Podcasts
Menopause training for HCPs
EMAS School
News
Events
Upcoming Events & Congress
Past EMAS Congresses
About EMAS
Mission & vision
Contact
Membership
Scientific Resources
Guidelines & Resources
Maturitas journal
Case Reports in Women’s Health
Research Update
Education
Upcoming EMAS Webinars
Webinars on-demand
Podcasts
Menopause training for HCPs
EMAS School
News
Events
Upcoming Events & Congress
Past EMAS Congresses
Role of progestogens in MHT (PT)
5 years ago
Portuguese
You may also like
Impact of estrogen deficiency on quality of life in Asia and the role of continuous combined MHT in treatment (PT)
2 years ago
Portuguese
How to handle the daily practice challenges when prescribing oral MHT (PT)
2 years ago
Portuguese
Benefits of oral combined MHT for estrogen deficiency symptoms treatment (PT)
2 years ago
Portuguese
Personalized oral combined MHT and long-term effects: How to choose according to the patient’s needs (PT)
3 years ago
Portuguese
Practical Aspects of MHT: Regimen, dosage, duration of treatment, and adverse events handling (PT)
3 years ago
Portuguese
Menopause beyond hot flushes: How to address common symptoms in the Asian population? (PT)
3 years ago
Portuguese
The long-term effects of oral combined estrogen + progestogen: Which patient profile benefits the most? (PT)
3 years ago
Portuguese
EMAS Roundtable: Hot issues on menopause (PT)
3 years ago
Portuguese
Ultra-low dose menopausal hormone therapy (PT)
3 years ago
Portuguese
Bleeding control algorithm when using MHT (PT)
4 years ago
Portuguese
See all Webinars
X